This could be the play of the year. This one has a huge catalyst next Friday, along with 18% short interest.

Greetings!  Just wanted to give everyone a heads-up on bio stock that has a major catalyst next Friday, plus there is a short interest of 18%.  I think this is a major play.  ChateGPT is forecasting over 100% - 200%+ gain if the short squeeze kicks in. Yes, I always use AI for calculations.

Anyway, the stock symbol is RARE, and to get right to it, they have a PDUFA date for an FDA decision next Saturday, September 19^(th), which means they would most likely make the announcement next Friday the 18^(th). Maybe even sooner.

Quick history, the company received a CRL last year based solely on the manufacturing plant.  They did the resubmission of the BLA, and the FDA has it on calendar by next Saturday.  That means the waiting is over.

It gets even better.  It was trading at $28 ten days ago, and it’s now at $14. It crashed because they failed to meet the endpoints on another drug, so this thing can be acquired right now at a major 50% discount.  I use ChatGPT for my research, but if anyone researches this, they will see that there is an extremely high probability rate of approval for this one.  It’s a binary play that is high risk high reward.

As far as what the FDA approval is based on, and all the details in between, you will have to do your own research and render your own decision.  Doing our own research is what this always comes down to.

Like I said though, we have a major catalyst plus with this, along major short squeeze play, and all within a week from now. This could be the play of the year if you ask me.

I’m not planning on posting this anywhere else.  You guys are the first and only ones to hear about this thing.

Let me know if anyone has any thoughts or feedback. I really like this one a lot.

Good luck to everyone!

Ryan